Cutler Group’s Vivani Medical VANI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-366
Closed -$596 5278
2022
Q3
$0 Sell
366
-17
-4% -$81 ﹤0.01% 5564
2022
Q2
$2K Sell
383
-304
-44% -$1.64K ﹤0.01% 4391
2022
Q1
$2K Buy
+687
New +$2.89K ﹤0.01% 4783
2021
Q4
Sell
-1,310
Closed -$9.58K 6132
2021
Q3
$12K Sell
1,310
-6,855
-84% -$77.2K ﹤0.01% 3792
2021
Q2
$121K Buy
8,165
+7,965
+3,983% +$154K 0.01% 1709
2021
Q1
$4K Buy
+200
New +$2.99K ﹤0.01% 4573
2017
Q2
Hold
0
7133
2017
Q1
Sell
-63
Closed -$2.41K 7268
2016
Q4
$2K Sell
63
-95
-60% -$5.43K ﹤0.01% 5725
2016
Q3
$13K Buy
158
+141
+829% +$12.5K ﹤0.01% 3922
2016
Q2
$1K Sell
17
-194
-92% -$20.2K ﹤0.01% 6291
2016
Q1
$24K Buy
211
+165
+359% +$19K ﹤0.01% 3106
2015
Q4
$6K Buy
+46
New +$6.73K ﹤0.01% 4747

Other funds holding VANI

Cutler Group's VANI Position: Q4 2022 in Review

Cutler Group sold out of Vivani Medical (VANI) in Q4 2022, closing a stake of 366 shares — an estimated $596 sold.

Cutler Group first reported a position in VANI in Q4 2015 and held it in 11 quarters. The position peaked at $121K in Q2 2021. 35 funds tracked by Wall St. Rank hold VANI as of Q4 2022.

  • Cutler Group reported no remaining Vivani Medical position as of Q4 2022 after selling out during the quarter.
  • Cutler Group sold 366 Vivani Medical shares in Q4 2022, an estimated $596.
  • Cutler Group first reported a position in Vivani Medical in Q4 2015 and held it in 11 quarters.
  • Cutler Group's Vivani Medical position peaked at $121K in Q2 2021.
  • 35 funds tracked by Wall St. Rank held Vivani Medical as of Q4 2022.

Based on Cutler Group's 13F filing for Q4 2022, filed 7 Feb 2023.